bioRxivMicrobiologyPreprint
SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals
Z. Li, J. Liu, H. Deng, X. Yang, H. Wang, X. Feng, G. Zelinskyy, M. Trilling, K. Sutter, M. Lu, B. Wang, D. Yang, X. Zheng, J. Liu
Abstract
An unaddressed key question in the current coronavirus disease 2019 (COVID-19) pandemic is the duration of immunity for which specific T cell responses against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are an indispensable element. Being situated in Wuhan where the pandemic initiated enables us to conduct the longest analyses of memory T cell responses against SARS-CoV-2 in COVID-19 convalescent individuals (CIs). Magnitude and breadth of SARS-CoV-2 memory CD4 and CD8 T cell responses were heterogeneous between patients but robust responses could be detected up to 9 months post disease onset in most CIs. Loss of memory CD4 and CD8 T cell responses were observed in only 16.13% and 25.81% of CIs, respectively. Thus, the overall magnitude and breadth of memory CD4 and CD8 T cell responses were quite stable and not inversely correlated with the time from disease onset. Interestingly, the only significant decrease in the response was found for memory CD4 T cells in the first 6-month post COVID-19 disease onset. Longitudinal analyses revealed that the kinetics of SARS-CoV-2 memory CD4 and CD8 T cell responses were quite heterogenous between patients. Loss of memory CD4 T cell responses was observed more frequently in asymptomatic cases than after symptomatic COVID-19. Interestingly, the few CIs in which SARS-CoV-2-specific IgG responses disappeared showed more durable memory CD4 T cell responses than CIs who remained IgG-positive for month. Collectively, we provide the first comprehensive characterization of the long-term memory T cell response in CIs, suggesting that SARS-CoV-2-specific T cell immunity is long-lasting in the majority of individuals.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Persistence of SARS-CoV-2 specific B- and T-cell responses in convalescent COVID-19 patients 6-8 months after the infection
N. Sherina, A. Piralla, … Q. Pan-Hammarstrom·bioRxiv·Nov 6, 2020
- Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
S. P. Anand, J. Prevost, … A. Finzi·bioRxiv·Jan 25, 2021
- Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
T. Sekine, A. Perez-Potti, … Karolinska COVID-19 Study Group·bioRxiv·Jun 29, 2020
- Longitudinal characterization of humoral and cellular immunity in hospitalized COVID-19 patients reveal immune persistence up to 9 months after infection
J. T. Sandberg, R. Varnaite, … S. Gredmark-Russ·bioRxiv·Mar 17, 2021
- Persistent Cellular Immunity to SARS-CoV-2 Infection
G. Breton, P. Mendoza, … M. C. Nussenzweig·bioRxiv·Dec 8, 2020
- Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period
E. Dawen, T. M. Narowski, … R. da Silva Antunes·bioRxiv·Mar 1, 2022